TETRAPHASE PHARMACEUTICALS INC Contracts & Agreements
89 Contracts & Agreements
- Business Finance (33 contracts)
- Business Operations (6)
- Human Resources (9)
- Intellectual Property (2)
- Mergers & Acquisitions (7)
- Real Estate (5)
- Uncategorized (27)
- Agreement and Plan of Merger by and among the Parent, the Purchaser and the Company, dated June 24, 2020 (Filed With SEC on June 24, 2020)
- Form of Contingent Value Rights Agreement, by and between the Parent and the Rights Agent (Filed With SEC on June 24, 2020)
- Form of Support Agreement, dated June 24, 2020, by and among the Parent, the Purchaser and the stockholder named therein (Filed With SEC on June 24, 2020)
- Form of Exchange Agreement, dated June 24, 2020, by and among the Parent, the Purchaser and the holder named therein (Filed With SEC on June 24, 2020)
- Agreement and Plan of Merger by and among the Parent, the Purchaser and the Company, dated June 4, 2020 (Filed With SEC on June 4, 2020)
- Form of Contingent Value Rights Agreement, by and between the Parent and the Rights Agent (Filed With SEC on June 4, 2020)
- Form of Support Agreement, dated June 4, 2020, by and among the Parent, the Purchaser and the stockholder named therein (Filed With SEC on June 4, 2020)
- Form of Exchange Agreement, dated June 4, 2020, by and among the Parent, the Purchaser and the holder named therein (Filed With SEC on June 4, 2020)
- Second Amendment to Agreement and Plan of Merger, by and among Parent, Merger Sub and Company, dated May 29, 2020 (Filed With SEC on May 29, 2020)
- Form of Contingent Value Rights Agreement, by and between AcelRx and the Rights Agent (Filed With SEC on May 29, 2020)
- Amendment to Agreement and Plan of Merger, by and among Parent, Merger Sub and Company, dated May 26, 2020 (Filed With SEC on May 27, 2020)
- Form of Contingent Value Rights Agreement, by and between AcelRx and the Rights Agent (Filed With SEC on May 27, 2020)
- Promissory Note, dated April 22, 2020, by and between Tetraphase Pharmaceuticals, Inc. and Silicon Valley Bank, N.A (Filed With SEC on April 28, 2020)
- Form of Contingent Value Rights Agreement, by and between the Parent and the Rights Agent (Filed With SEC on March 16, 2020)
- Co-Promotion Agreement, dated March 15, 2020, by and between the Parent and the Company (Filed With SEC on March 16, 2020)
- Form of Voting Agreement, dated March 15, 2020, by and among the Parent, Merger Sub and the stockholder named therein (Filed With SEC on March 16, 2020)
- Form of Exchange Agreement, dated March 15, 2020, by and among the Parent, Merger Sub and the holder named therein (Filed With SEC on March 16, 2020)
- Agreement and Plan of Merger by and among Parent, Merger Sub and Company, dated March 15, 2020 (Filed With SEC on March 16, 2020)
- Description of Registrants Securities (Filed With SEC on March 12, 2020)
- Amendment, dated January 31, 2020, to Lease Agreement, dated as of November 16, 2006, by and between the Registrant and ARE-480 Arsenal Street, LLC, as amended (Filed With SEC on March 12, 2020)
- Form of Unregistered Pre-Funded Warrant (Filed With SEC on January 23, 2020)
- Form of Unregistered Common Warrant (Filed With SEC on January 23, 2020)
- Form of Registered Pre-Funded Warrant (Filed With SEC on January 23, 2020)
- Form of Registered Common Warrant (Filed With SEC on January 23, 2020)
- Form of PIPE Securities Purchase Agreement, dated January 22, 2020, by and among the Company and the other persons party thereto (Filed With SEC on January 23, 2020)
- Form of Registration Rights Agreement, dated January 22, 2020, by and among the Company and the other persons party thereto (Filed With SEC on January 23, 2020)
- Form of RD Securities Purchase Agreement, dated January 22, 2020, by and among the Company and the other persons party thereto (Filed With SEC on January 23, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on October 30, 2019)
- Form of Common Stock Warrant (Filed With SEC on October 30, 2019)
- Form of Securities Purchase Agreement, dated October 29, 2019, between the Company and the Purchaser (Filed With SEC on October 30, 2019)
- Payoff Letter, entered into as of August 30, 2019, by and among Tetraphase Pharmaceuticals, Inc., Solar Capital Ltd., as collateral agent and lender, and the other lenders named... (Filed With SEC on August 30, 2019)
- Amendment No.1, dated July 29, 2019, to the License Agreement between Everest Medicines Limited and the Registrant (Filed With SEC on August 8, 2019)
- Offer letter, dated as of July 31, 2019, by and between the Registrant and Larry Edwards (Filed With SEC on August 8, 2019)
- Separation agreement, dated as of July 31, 2019, by and between the Registrant and Guy Macdonald (Filed With SEC on August 8, 2019)
- Consulting agreement, dated as of July 31, 2019, by and between the Registrant and Guy Macdonald (Filed With SEC on August 8, 2019)
- Amendment No. 1 to Tetraphase Pharmaceuticals, Inc. 2014 Employee Stock Purchase Plan, dated March 13, 2019 (Filed With SEC on May 8, 2019)
- First Amendment to Loan and Security Agreement, dated as of March 14, 2019, by and between the registrant and Solar Capital Ltd., in its capacity as collateral agent (Filed With SEC on May 8, 2019)
- Amendment, dated November 29, 2018, to Lease Agreement, dated as of November 16, 2006, by and between the Registrant and ARE-480 Arsenal Street, LLC, as amended (Filed With SEC on March 15, 2019)
- Form of Warrant to Purchase Stock entered into in connection with the Loan and Security Agreement, dated as of November 2, 2018 (Filed With SEC on November 5, 2018)
- Loan and Security Agreement, dated November 2, 2018, by and among Tetraphase Pharmaceuticals, Inc., Solar Capital Ltd., as collateral agent and lender, and the other lenders named... (Filed With SEC on November 5, 2018)
- Offer letter, dated as of December 27, 2017, by and between the Registrant and Larry Tsai (Filed With SEC on March 6, 2018)
- Amendment, dated as of December 5, 2017, by and between the Registrant and the President and Fellows of Harvard College, as amended (Filed With SEC on March 6, 2018)
- License Agreement, dated February 20, 2018, by and between the Registrant and Everest Medicines Limited (Filed With SEC on March 6, 2018)
- Offer letter, dated as of March 1, 2018, by and between the Registrant and Larry Edwards (Filed With SEC on March 6, 2018)
- Commercial Supply Agreement, dated October 16, 2017, by and between the Registrant and Finorga SAS (Filed With SEC on November 1, 2017)
- Offer Letter, dated as of September 21, 2017, by and between the Registrant and Kamalam Unninayar (Filed With SEC on November 1, 2017)
- 10,000,000 TETRAPHASEPHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on July 28, 2017)
- TETRAPHASE PHARMACEUTICALS, INC. CONTROLLED EQUITY OFFERINGSM AMENDMENT NO. 1 TO SALES AGREEMENT (Filed With SEC on July 7, 2017)
- Tetraphase Pharmaceuticals, Inc. Restricted Stock Unit Agreement Granted Under 2013 Stock Incentive Plan NOTICE OF GRANT (Filed With SEC on March 13, 2017)
- TETRAPHASE PHARMACEUTICALS, INC. Up to $40,000,000 Shares of CommonStock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on January 17, 2017)
- SEVENTH AMENDMENT TO LEASE (Filed With SEC on August 6, 2015)
- SIXTH AMENDMENT TO LEASE (Filed With SEC on May 7, 2015)
- - 2 - (Filed With SEC on May 7, 2015)
- Tetraphase Pharmaceuticals, Inc. Nonstatutory Stock Option Agreement (Filed With SEC on May 7, 2015)
- 4,300,000 TETRAPHASEPHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 12, 2015)
- CONSENT AND SECOND AMENDMENT TO LOANAND SECURITY AGREEMENT (Filed With SEC on March 6, 2015)
- CONSENT AND THIRD AMENDMENT TO LOANAND SECURITY AGREEMENT (Filed With SEC on March 6, 2015)
- FIFTH AMENDMENT TO LEASE (Filed With SEC on November 10, 2014)
- 3,950,000 TETRAPHASEPHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 17, 2014)
- Tetraphase Pharmaceuticals, Inc. 2014 EMPLOYEE STOCK PURCHASE PLAN April 25, 2014 (Filed With SEC on August 12, 2014)
- SECOND AMENDMENT TO OFFER LETTER (Filed With SEC on May 12, 2014)
- THIRD AMENDMENT TO OFFER LETTER (Filed With SEC on May 12, 2014)
- AMENDMENT TO OFFER LETTER (Filed With SEC on May 12, 2014)
- LEASEAGREEMENT (Filed With SEC on March 6, 2014)
- [] TETRAPHASEPHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on November 4, 2013)
- 6,818,181 TETRAPHASE PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 5, 2013)
- Additional abbreviations may also be used though not in the above list. (Filed With SEC on March 5, 2013)
- Tetraphase Pharmaceuticals, Inc. Incentive Stock Option Agreement Granted Under 2006 Stock IncentivePlan (Filed With SEC on March 5, 2013)
- TETRAPHASE PHARMACEUTICALS, INC. 2013 STOCK INCENTIVE PLAN February 26, 2013 (Filed With SEC on March 5, 2013)
- TETRAPHASE PHARMACEUTICALS, INC. INCENTIVE STOCK OPTION AGREEMENT GRANTED UNDER 2013 STOCK INCENTIVE PLAN (Filed With SEC on March 5, 2013)
- TETRAPHASE PHARMACEUTICALS, INC. NONSTATUTORY STOCK OPTION AGREEMENT GRANTED UNDER 2013 STOCK INCENTIVE PLAN (Filed With SEC on March 5, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on March 5, 2013)
- INDEMNIFICATION AGREEMENT (Filed With SEC on March 5, 2013)
- SECOND AMENDED AND RESTATED REGISTRATION RIGHTSAGREEMENT (Filed With SEC on February 11, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on February 11, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on February 11, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on February 11, 2013)
- TETRAPHASE PHARMACEUTICALS, INC. 2006 STOCK INCENTIVEPLAN1 (Filed With SEC on February 11, 2013)
- Tetraphase Pharmaceuticals, Inc. Incentive Stock Option Agreement Granted Under 2006 Stock Incentive Plan (Filed With SEC on February 11, 2013)
- Tetraphase Pharmaceuticals, Inc. Nonstatutory Stock Option Agreement Granted Under 2006 Stock Incentive Plan (Filed With SEC on February 11, 2013)
- TETRAPHASE PHARMACEUTICALS, INC. August 10, 2006 (Filed With SEC on February 11, 2013)
- TetraphasePharmaceuticals, Inc. Confidential (Filed With SEC on February 11, 2013)
- Tetraphase Pharmaceuticals, Inc. Confidential (Filed With SEC on February 11, 2013)
- INDEMNIFICATION AGREEMENT (Filed With SEC on February 11, 2013)
- INDEMNIFICATION AGREEMENT (Filed With SEC on February 11, 2013)
- INDEMNIFICATION AGREEMENT (Filed With SEC on February 11, 2013)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on February 11, 2013)
- LEASEAGREEMENT (Filed With SEC on February 11, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on February 11, 2013)